LAMELLASOME CF-NA

N/A

Report date: 2024/09/19 15:13:39

Base Information

Drug NameLAMELLASOME CF-NA
Drug Alias NameCFTR gene therapyPlasmid DNA-based replacement therapy
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator stimulants
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesLamellar Biomedical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLamellar Biomedical LtdThe University Of Edinburgh
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A